Get to know BioNTech
Biopharmaceutical New Technologies (BioNTech) is a global, next generation immunotherapy company pioneering novel, investigative therapies for cancer and other serious diseases. With a steadfast commitment to scientific rigor and operational excellence, BioNTech exploits a wide array of computational discovery and therapeutic modalities with the intent to rapidly develop novel biopharmaceuticals. The company’s diversified portfolio aims to address the full continuum of cancer with oncology product candidates, including mRNA cancer immunotherapies, next-generation immunomodulators and targeted therapies such as antibody-drug conjugates (ADCs) and innovative chimeric antigen receptor (CAR) T cell therapies. Leveraging key capabilities in mRNA research and development, in-house manufacturing, immunology, deep genomics and AI, BioNTech and its collaborators are researching and developing multiple mRNA vaccine candidates for a range of infectious diseases alongside its diverse oncology pipeline.
Annual report
In 2024, BioNTech achieved significant progress, with priority programs progressing into late-stage development and enhanced AI capabilities. Access our annual report for the year 2024 for insights into corporate and scientific milestones, comprehensive pipeline updates and a summary of our financial results.
Download the 2024 annual report
15 MB / PDF
Explore more about BioNTech
Our board members
Meet the leaders driving our efforts to leverage the immune system to develop treatments for diseases with unmet and/or high medical need.
Our collaborators
Discover how our partnerships and collaborations with a number of the world’s most established biotechnology and pharmaceutical companies, academia and non-profit organizations help us drive medical breakthroughs and therapeutic innovations to improve standard of care.
Our sites and subsidiaries
BioNTech’s global site network integrates capabilities from discovery to delivery that fuel the research, development and commercialization of novel immunotherapies and vaccines.
Our corporate sustainability and responsibility
Find out how BioNTech’s commitment to innovation, transparency, and sustainability supports global health and responsible governance.
